Giordano Christopher Thomas
Tenax Therapeutics, Inc. · CEO
Giordano Christopher Thomas is listed in filings as CEO at Tenax Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 13, 2026, including purchase activity. Recent filings connect the profile to Tenax Therapeutics, Inc. (TENX). The current snapshot covers public activity from Nov 20, 2025 to Jan 13, 2026. Reported amounts are shown as $12.5K to $4.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $13k1.6k shares | BuyNov 18, 2025 | $7.75 | $15.83 | |
| $3.4k455 shares | BuyNov 19, 2025 | $7.51 | $15.83 |